Spots Global Cancer Trial Database for saha
Every month we try and update this database with for saha cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | NCT01983969 | Advanced Cancer... Lymphoma | Azacitidine Vorinostat Gemcitabine Busulfan Melphalan Dexamethasone Caphosol Glutamine Pyridoxine Rituximab | 15 Years - 65 Years | M.D. Anderson Cancer Center | |
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease | NCT04339751 | Cushing's Disea... | Vorinostat | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) | NCT00948064 | Leukemia | Vorinostat Azacitidine | 18 Years - | M.D. Anderson Cancer Center | |
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma | NCT00787527 | Lymphoma | Zolinza (vorino... Cyclophosphamid... Doxorubicin Vincristine Prednisone | 18 Years - | M.D. Anderson Cancer Center | |
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma | NCT00810576 | Lymphoma | Vorinostat Bortezomib | 18 Years - | M.D. Anderson Cancer Center | |
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) | NCT01110876 | Brain Cancer Glioblastoma Mu... | Vorinostat Erlotinib Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | NCT02114502 | Myeloma | Carfilzomib SAHA Gemcitabine Busulfan Melphalan Stem Cell Trans... Palifermin Dexamethasone Caphosol Glutamine Pyridoxine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies | NCT02042989 | Advanced Cancer... | MLN9708 Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Vorinostat Plus Radiation Therapy in Pancreatic Cancer | NCT00831493 | Pancreatic Canc... | Chemoradiation ... Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer | NCT01266057 | Advanced Cancer... | Hydroxychloroqu... Sirolimus Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Study of Curcumin, Vorinostat, and Sorafenib | NCT01608139 | Advanced Cancer... | Curcumin Sorafenib Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Study of Curcumin, Vorinostat, and Sorafenib | NCT01608139 | Advanced Cancer... | Curcumin Sorafenib Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Study of Curcumin, Vorinostat, and Sorafenib | NCT01608139 | Advanced Cancer... | Curcumin Sorafenib Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Vorinostat Plus Radiation Therapy in Pancreatic Cancer | NCT00831493 | Pancreatic Canc... | Chemoradiation ... Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat | NCT00791011 | Hodgkin's Lymph... Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Diffuse Large C... | AMG 655 Vorinostat Bortezomib | 18 Years - | Amgen | |
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer | NCT01266057 | Advanced Cancer... | Hydroxychloroqu... Sirolimus Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) | NCT00555399 | Glioblastoma Mu... Anaplastic Glio... | Vorinostat Isotretinoin Surgical Resect... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies | NCT02042989 | Advanced Cancer... | MLN9708 Vorinostat | 18 Years - | M.D. Anderson Cancer Center | |
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat | NCT00791011 | Hodgkin's Lymph... Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Diffuse Large C... | AMG 655 Vorinostat Bortezomib | 18 Years - | Amgen | |
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | NCT02589145 | Lymphoma | Lenalidomide Vorinostat Gemcitabine Busulfan Melphalan Rituximab Dexamethasone Caphosol Glutamine Pyridoxine Enoxaparin Stem Cell Trans... Palifermin | 15 Years - 65 Years | M.D. Anderson Cancer Center |